These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12438602)

  • 1. Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.
    Wu H; Dmitriev I; Kashentseva E; Seki T; Wang M; Curiel DT
    J Virol; 2002 Dec; 76(24):12775-82. PubMed ID: 12438602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon.
    Tian X; Su X; Li H; Li X; Zhou Z; Liu W; Zhou R
    Virus Res; 2011 Sep; 160(1-2):214-20. PubMed ID: 21740937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E.
    Ostapchuk P; Hearing P
    J Virol; 2001 Jan; 75(1):45-51. PubMed ID: 11119572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
    Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
    Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.
    Gall JG; Crystal RG; Falck-Pedersen E
    J Virol; 1998 Dec; 72(12):10260-4. PubMed ID: 9811772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.
    Bruder JT; Semenova E; Chen P; Limbach K; Patterson NB; Stefaniak ME; Konovalova S; Thomas C; Hamilton M; King CR; Richie TL; Doolan DL
    PLoS One; 2012; 7(4):e33920. PubMed ID: 22496772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
    Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
    J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of adenovirus serotype 35 as a gene transfer vector.
    Seshidhar Reddy P; Ganesh S; Limbach MP; Brann T; Pinkstaff A; Kaloss M; Kaleko M; Connelly S
    Virology; 2003 Jul; 311(2):384-93. PubMed ID: 12842627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexon gene switch strategy for the generation of chimeric recombinant adenovirus.
    Youil R; Toner TJ; Su Q; Chen M; Tang A; Bett AJ; Casimiro D
    Hum Gene Ther; 2002 Jan; 13(2):311-20. PubMed ID: 11812286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
    Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
    Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectors.
    Yan J; Dong J; Wu J; Zhu R; Wang Z; Wang B; Wang L; Wang Z; Zhang H; Wu H; Yu B; Kong W; Yu X
    Sci Rep; 2016 Mar; 6():22464. PubMed ID: 26934960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of sites in adenovirus hexon for foreign peptide incorporation.
    Wu H; Han T; Belousova N; Krasnykh V; Kashentseva E; Dmitriev I; Kataram M; Mahasreshti PJ; Curiel DT
    J Virol; 2005 Mar; 79(6):3382-90. PubMed ID: 15731232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.
    Gall J; Kass-Eisler A; Leinwand L; Falck-Pedersen E
    J Virol; 1996 Apr; 70(4):2116-23. PubMed ID: 8642632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.
    Harmon AW; Moitra R; Xu Z; Byrnes AP
    PLoS One; 2018; 13(2):e0192353. PubMed ID: 29401488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions.
    Bradley RR; Maxfield LF; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
    J Virol; 2012 Jan; 86(2):1267-72. PubMed ID: 22072746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumvention of immunity to the adenovirus major coat protein hexon.
    Roy S; Shirley PS; McClelland A; Kaleko M
    J Virol; 1998 Aug; 72(8):6875-9. PubMed ID: 9658137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon.
    Su X; Tian X; Jiang Z; Ma Q; Liu Q; Lu X; Zhou R
    PLoS One; 2016; 11(6):e0156984. PubMed ID: 27328032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
    Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS
    J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Ad5H3 Chimera Using the "Antigen Capsid-Incorporation" Strategy for an Alternative Vaccination Approach.
    Gu L; Icyuz M; Krendelchtchikova V; Krendelchtchikov A; Johnston AE; Matthews QL
    Open Virol J; 2016; 10():10-20. PubMed ID: 27335626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.